Special Report

Most Read

Scenario Top

Special Report By Sharon Begley

Three potential futures for Covid-19: recurring small outbreaks, a monster wave, or a persistent crisis

Adams brothers - photo collage

Special Report By Andrew Joseph

The surgeon general and his brother: A family’s painful reckoning with addiction

Special Report By Andrew Joseph

As the coronavirus spreads, a drug that once raised the world’s hopes is given a second shot

Alternative Medicine

Special Report By Casey Ross, Max Blau, and Kate Sheridan

Medicine with a side of mysticism: Top hospitals promote unproven therapies

Penicillium

Special Report By Gardiner Harris and Alex W. Palmer — The Wire

China has near-total control of the world’s antibiotic supply. Is America at risk as a result?

Faces

Special Report By David Armstrong

52 weeks, 52 faces: Obituaries narrate lives lost to the opioid epidemic

Special Report By Megan Thielking

Celebrity-backed shows make bold pitches to health care companies — and charge big bucks. But the experiences don’t always deliver

GSK illo

Special Report By David Barboza — The Wire

After a bribery scandal in China, GSK found a suspected whistleblower. The real one is still waiting in the shadows

All Coverage

Special Report By Lev Facher

Pharma is showering Congress with cash, even as drug makers race to fight the coronavirus

Soon Shiong Collage

Special Report By Rebecca Robbins and Adam Feuerstein

Harry Reid and Alex Trebek tried Patrick Soon-Shiong’s experimental cancer therapy. Can their results be duplicated in a clinical trial?

advertisement

AI hospital care

Special Report By Rebecca Robbins and Erin Brodwin

An invisible hand: Patients aren’t being told about the AI systems advising their care

CDC Moat

Special Report By Nicholas Florko

The CDC has always been an apolitical island. That’s left it defenseless against Trump

The cliff -illustration

Special Report By Megan Thielking

Facing a broken mental health system, many U.S. teens fall off a dangerous ‘cliff’ in their care

Atul Haven photo illustration

Special Report By Erin Brodwin and Casey Ross

Two years of halting progress and high turnover preceded Atul Gawande’s exit as Haven CEO

Gilead White House photo illo

Special Report By Nicholas Florko and Damian Garde

With remdesivir, Gilead finds itself at strategic crossroads, with its reputation (and far more) at stake

Virus Outbreak Idaho

Special Report By Andrew Joseph

Coronavirus pandemic threatens to take crushing toll on rural areas, data show

empty schoolyard - San Francisco

Special Report By Sharon Begley

When can we let up? Health experts craft strategies to safely relax coronavirus lockdowns

Walmart health illustration

Special Report By Megan Thielking

‘A Supercenter for health’: Walmart places a big bet on cheaper, less intimidating primary care

Morgantown

Special Report By Natasha Gilbert

‘Dump it down the drain’: How contaminants from prescription-drug factories pollute waterways

Medicine Hunters Part 2

Special Report By Eric Boodman

The Medicine Hunters, Part II: Toxic weed fuels a cancer-drug gold rush — and a quandary

Medicine Hunters Part 1

Special Report By Eric Boodman

The Medicine Hunters, Part I: Before signing up for a trial, one patient wants to know if the drug will be affordable

The future of Alzheimer's

Special Report By Sharon Begley

Forecasting Alzheimer’s: With a tsunami of new diagnoses expected, experts calculate the best ways to shift the tide

Ting Han

Special Report By Diana Cai

Chinese scientists came to the U.S. to pursue their dreams. Under tighter scrutiny, many are returning home

Mari-Hélène avec Tobie

Special Report By Eric Boodman

The vaccine whisperers: Counselors gently engage new parents before their doubts harden into certainty

Pharma wins in Washington illustration

Special Report By Nicholas Florko and Lev Facher

How pharma, under attack from all sides, keeps winning in Washington

Alzheimer's research

Special Report By Sharon Begley

The maddening saga of how an Alzheimer’s ‘cabal’ thwarted progress toward a cure for decades

Rx overprescribing KHN

Special Report By Julie Appleby and Elizabeth Lucas — Kaiser Health News

While addiction crisis raged, many surgeons overprescribed opioids, analysis shows

Hydrocodone Acetaminophen

Special Report By Kaiser Health News

How the Kaiser-Johns Hopkins analysis was done

Jaci Hermstad

Special Report By Nicholas Florko

When ‘right to try’ isn’t enough: Congress wants a single ALS patient to get a therapy never tested in humans

TUFTS - Sackler

Special Report By Andrew Joseph

‘We owe much to the Sackler family’: How gifts to a top medical school advanced the interests of Purdue Pharma

James High

Special Report By Eric Boodman

Their baby died during his nap. Then medical bureaucrats deepened the parents’ anguish

Richard Sackler

Special Report By David Armstrong — ProPublica

Purdue’s Sackler embraced plan to conceal OxyContin’s strength from doctors, sealed deposition shows

STAT Purdue illustration

Special Report By David Armstrong — ProPublica

Document: Facing blame for seeding the opioid crisis, Purdue explored its next profit opportunity — treating addiction